These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 27539645)

  • 1. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads.
    Cheng Y; Gao H; Tang L; Li J; Yao L
    Echocardiography; 2016 Nov; 33(11):1689-1696. PubMed ID: 27539645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
    Mediratta A; Addetia K; Yamat M; Moss JD; Nayak HM; Burke MC; Weinert L; Maffessanti F; Jeevanandam V; Mor-Avi V; Lang RM
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):337-47. PubMed ID: 24631508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permanent cardiac pacing and its influence on tricuspid valve function.
    Krupa W; Kozłowski D; Derejko P; Swiatecka G
    Folia Morphol (Warsz); 2001 Nov; 60(4):249-57. PubMed ID: 11770335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: role of real time three-dimensional echocardiography.
    Nucifora G; Badano LP; Allocca G; Gianfagna P; Proclemer A; Cinello M; Fioretti PM
    Echocardiography; 2007 Jul; 24(6):649-52. PubMed ID: 17584205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional color Doppler echocardiographic quantification of tricuspid regurgitation orifice area: comparison with conventional two-dimensional measures.
    Chen TE; Kwon SH; Enriquez-Sarano M; Wong BF; Mankad SV
    J Am Soc Echocardiogr; 2013 Oct; 26(10):1143-1152. PubMed ID: 23993694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads.
    Seo Y; Ishizu T; Nakajima H; Sekiguchi Y; Watanabe S; Aonuma K
    Circ J; 2008 Sep; 72(9):1465-70. PubMed ID: 18724023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricuspid Valve Dysfunction Caused by Right Ventricular Leads.
    Ebrille E; Chang JD; Zimetbaum PJ
    Card Electrophysiol Clin; 2018 Sep; 10(3):447-452. PubMed ID: 30172281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
    Schleifer JW; Pislaru SV; Lin G; Powell BD; Espinosa R; Koestler C; Thome T; Polk L; Li Z; Asirvatham SJ; Cha YM
    Heart Rhythm; 2018 Jul; 15(7):1009-1016. PubMed ID: 29496605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pacemaker-induced tricuspid regurgitation is uncommon immediately post-implantation.
    Rothschild DP; Goldstein JA; Kerner N; Abbas AE; Patel M; Wong WS
    J Interv Card Electrophysiol; 2017 Sep; 49(3):281-287. PubMed ID: 28685199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
    Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of implantable transvenous device lead location on severity of tricuspid regurgitation.
    Addetia K; Maffessanti F; Mediratta A; Yamat M; Weinert L; Moss JD; Nayak HM; Burke MC; Patel AR; Kruse E; Jeevanandam V; Mor-Avi V; Lang RM
    J Am Soc Echocardiogr; 2014 Nov; 27(11):1164-75. PubMed ID: 25129393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
    J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximal isovelocity surface area by single-beat three-dimensional color Doppler echocardiography applied for tricuspid regurgitation quantification.
    de Agustin JA; Viliani D; Vieira C; Islas F; Marcos-Alberca P; Gomez de Diego JJ; Nuñez-Gil IJ; Almeria C; Rodrigo JL; Luaces M; Garcia-Fernandez MA; Macaya C; Perez de Isla L
    J Am Soc Echocardiogr; 2013 Sep; 26(9):1063-72. PubMed ID: 23860094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac implantable electronic device-induced tricuspid regurgitation: Implications and management.
    Murphy SP; Lew J; Yucel E; Singh J; Mela T
    J Cardiovasc Electrophysiol; 2024 May; 35(5):1017-1025. PubMed ID: 38501386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new view of an unusual pacemaker complication: role of three-dimensional transthoracic echocardiography.
    Miglioranza MH; Becker D; Jiménez-Nácher JJ; Moya JL; Golfin CF; Zamorano JL
    Echocardiography; 2013 Jul; 30(6):E164-6. PubMed ID: 23551119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of functional tricuspid regurgitation using 320-detector-row multislice computed tomography: risk factor analysis for recurrent regurgitation after tricuspid annuloplasty.
    Kabasawa M; Kohno H; Ishizaka T; Ishida K; Funabashi N; Kataoka A; Matsumiya G
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):312-20. PubMed ID: 23246056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
    Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
    Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads.
    Najib MQ; Vittala SS; Challa S; Raizada A; Tondato FJ; Lee HR; Chaliki HP
    Tex Heart Inst J; 2013; 40(5):529-33. PubMed ID: 24391312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entrapment of permanent pacemaker lead as the cause of tricuspid regurgitation.
    Chen TE; Wang CC; Chern MS; Chu JJ
    Circ J; 2007 Jul; 71(7):1169-71. PubMed ID: 17587731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.